Raksha Jain, M.D.
Raksha Jain grew up in the Dallas area with an interest in the sciences. She received her B.S. in Biology at the Massachusetts Institute of Technology and attended medical school at the University of Texas Health Science Center in Houston. She trained in internal medicine at UT Southwestern and served as Chief Resident.
Raksha Jain grew up in the Dallas area with an interest in the sciences. She received her B.S. in Biology at the Massachusetts Institute of Technology and attended medical school at the University of Texas Health Science Center in Houston. She trained in internal medicine at UT Southwestern and served as Chief Resident. She completed her pulmonary and critical care fellowship and Masters of Science in Clinical Investigation at Washington University in St. Louis, Missouri, where she developed her interest in cystic fibrosis and jointly trained in laboratory and clinically based research. Raksha Jain is an Associated Professor of Medicine in Pulmonary and Critical Care Medicine and has been at UT Southwestern since 2010, where she serves as Medical Director of the Adult Cystic Fibrosis Program. Dr. Jain leads a number of clinical trials on novel therapies for cystic fibrosis. She focuses her translational research on sex hormones and their influence on host immune responses to infection with an emphasis on Pseudomonas aeruginosa, a devastating pathogen in cystic fibrosis. When not at work, she enjoys spending time with her husband and her two children, and loves sports, including soccer.
She completed her pulmonary and critical care fellowship and Masters of Science in Clinical Investigation at Washington University in St. Louis, Missouri, where she developed her interest in cystic fibrosis and jointly trained in laboratory and clinically based research.
Raksha Jain is an Associated Professor of Medicine in Pulmonary and Critical Care Medicine and has been at UT Southwestern since 2010, where she serves as Medical Director of the Adult Cystic Fibrosis Program.
Dr. Jain leads several clinical trials on novel therapies for cystic fibrosis. She focuses her translational research on sex hormones and their influence on host immune responses to infection with an emphasis on Pseudomonas aeruginosa, a devastating pathogen in cystic fibrosis.
When not at work, she enjoys spending time with her husband and her two children, and loves sports, including soccer.